Ignite Creation Date:
2024-05-06 @ 2:17 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04278768
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2020-02-10
Brief Title:
Dose Escalation Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia AML or Myelodysplastic Syndrome MDS
Sponsor:
Curis Inc
Organization:
Curis Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndrome |
| Acute Myelogenous Leukemia |
Keywords:
| Name | View |
|---|---|
| Acute Myelogenous Leukemia | View |
| Myelodysplastic Syndrome | View |
| AML | View |
| MDS | View |
| IRAK4 | View |
| FLT3-ITD mutant | View |
| FLT3 Wild Type WT | View |
| resistantrefractory to HMA | View |
| spliceosome mutation | View |
| SF3B1 | View |
| U2AF1 | View |
| SRSF2 | View |
| ZRSR2 | View |
| high risk AML | View |
| high risk MDS | View |
| resistantrefractory to rr to HMA | View |
| failing prior treatment | View |